Merck's Gardasil 9 launches in Canada; Immunomic wins NIH grant for peanut allergy candidate;

> Merck's ($MRK) Gardasil 9 has launched in Canada. Release

> Immunomic Therapeutics has won a Small Business Innovation Research grant from the NIH for its work on a peanut allergy vaccine. Release

> Diabetes vaccine maker Diamyd Medical has received 15 million Swedish krona ($1.7 million) in a direct issue. Release

> The human vaccine market in China is slated to jump as R&D and production capacity grow. Release

And Finally... Geovax has assigned a trial number to the next study of its candidate HIV preventive. Release

Suggested Articles

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.

Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.

Experts are pushing for the introduction of J&J's vaccine in the response to the Ebola outbreak in the Democratic Republic of Congo.